GENMAB AS SP.ADR/1/10DK 1 (GE91) — Working Capital to Net Assets Ratio
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Working Capital to Net Assets ratio of 24.9% as of December 2025. Working capital of €1.46 Billion (current assets of €2.88 Billion minus current liabilities of €1.43 Billion) is measured against net assets of €5.85 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of GENMAB AS SP.ADR/1/10DK 1 to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GENMAB AS SP.ADR/1/10DK 1 Working Capital to Net Assets (2021–2025)
This chart shows how GENMAB AS SP.ADR/1/10DK 1's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 24.9%, reflecting working capital of €1.46 Billion against net assets of €5.85 Billion EUR. Check GE91 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see GENMAB AS SP.ADR/1/10DK 1 (GE91) market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 24.9% | €1.46 Billion | €5.85 Billion | €2.88 Billion | €1.43 Billion | ▼ -36.5 pp |
| 2024 | 61.4% | €3.15 Billion | €5.12 Billion | €3.89 Billion | €740.55 Million | ▼ -35.5 pp |
| 2023 | 97.0% | €4.55 Billion | €4.69 Billion | €4.92 Billion | €368.80 Million | ▲ +0.2 pp |
| 2022 | 96.7% | €3.80 Billion | €3.93 Billion | €4.06 Billion | €262.38 Million | ▲ +1.4 pp |
| 2021 | 95.4% | €3.22 Billion | €3.38 Billion | €3.46 Billion | €238.71 Million | — |